1. Home
  2. SLGL vs SELF Comparison

SLGL vs SELF Comparison

Compare SLGL & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • SELF
  • Stock Information
  • Founded
  • SLGL 1997
  • SELF 1983
  • Country
  • SLGL Israel
  • SELF United States
  • Employees
  • SLGL N/A
  • SELF N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • SELF Real Estate Investment Trusts
  • Sector
  • SLGL Health Care
  • SELF Real Estate
  • Exchange
  • SLGL Nasdaq
  • SELF Nasdaq
  • Market Cap
  • SLGL 49.4M
  • SELF 58.8M
  • IPO Year
  • SLGL 2018
  • SELF N/A
  • Fundamental
  • Price
  • SLGL $23.48
  • SELF $5.28
  • Analyst Decision
  • SLGL Buy
  • SELF
  • Analyst Count
  • SLGL 1
  • SELF 0
  • Target Price
  • SLGL $40.00
  • SELF N/A
  • AVG Volume (30 Days)
  • SLGL 30.1K
  • SELF 34.1K
  • Earning Date
  • SLGL 08-15-2025
  • SELF 08-08-2025
  • Dividend Yield
  • SLGL N/A
  • SELF 5.52%
  • EPS Growth
  • SLGL N/A
  • SELF 9.99
  • EPS
  • SLGL N/A
  • SELF 0.22
  • Revenue
  • SLGL $23,931,000.00
  • SELF $12,707,884.00
  • Revenue This Year
  • SLGL N/A
  • SELF N/A
  • Revenue Next Year
  • SLGL $31.17
  • SELF N/A
  • P/E Ratio
  • SLGL N/A
  • SELF $23.78
  • Revenue Growth
  • SLGL 264.86
  • SELF 4.08
  • 52 Week Low
  • SLGL $4.01
  • SELF $4.78
  • 52 Week High
  • SLGL $26.89
  • SELF $5.89
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 72.14
  • SELF 55.26
  • Support Level
  • SLGL $20.06
  • SELF $4.99
  • Resistance Level
  • SLGL $26.89
  • SELF $5.16
  • Average True Range (ATR)
  • SLGL 2.57
  • SELF 0.13
  • MACD
  • SLGL 0.63
  • SELF 0.02
  • Stochastic Oscillator
  • SLGL 75.10
  • SELF 90.63

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About SELF Global Self Storage Inc.

Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.

Share on Social Networks: